Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,436,001
-$170,002 QoQ
Shares Held
37,154
-5.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.83%
of 13F equity value
Holder Rank
#1,149
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Core Alternative Capital holds $26,259,704 across 8 Drug Manufacturers - General names. JNJ ranks #1 (35.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
37,154 | $9,436,001 | |
| 2 | LLY |
ELI LILLY & Co
|
7,645 | $9,169,643 | |
| 3 | MRK |
Merck & Co., Inc.
|
39,979 | $5,137,301 | |
| 4 | AMGN |
Amgen Inc
|
3,151 | $1,141,040 | |
| 5 | ABBV |
AbbVie Inc.
|
2,976 | $748,880 | |
| 6 | PFE |
Pfizer Inc
|
13,063 | $314,557 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,189 | $276,558 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
620 | $35,724 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,436,001 | 37,154 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,606,003 | 39,298 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $8,487,019 | 41,010 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $7,471,313 | 40,294 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $6,941,112 | 45,441 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $8,120,023 | 48,963 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $8,349,780 | 57,736 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $9,751,312 | 60,171 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,677,692 | 66,213 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $11,805,245 | 74,627 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,320,392 | 84,984 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,394,089 | 105,259 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $18,241,959 | 110,210 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $19,019,585 | 122,707 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $21,742,435 | 123,082 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $16,344,494 | 100,052 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $10,554,389 | 59,458 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $8,748,427 | 49,362 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $9,930,613 | 58,050 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,272,845 | 57,417 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $8,330,737 | 50,569 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $6,872,130 | 41,814 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,229,572 | 39,583 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,475,508 | 36,778 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $5,645,731 | 40,146 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $5,823,745 | 44,412 | Shares | Sole | 2020-06-09 | |
| No filing history on record for this holder in this stock. | ||||||